Surveillance of Dutch Patients With Li-Fraumeni Syndrome: The LiFe-Guard Study.

Abstract

This cohort study of patients with Li-Fraumeni syndrome assesses the diagnostic yield and false-positive rate of an annual surveillance program including whole-body magnetic resonance imaging in patients identified as carriers of TP53 gene mutations.

More about this publication

JAMA oncology
  • Volume 3
  • Issue nr. 12
  • Pages 1733-1734
  • Publication date 01-12-2017

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.